Abstract
A biased chemical library containing 91 differentially substituted thiazolidinones was prepared in an effort to improve the pharmacology of a known anticonvulsant agent V102862. The collection was prepared in a single step multi-component condensation reaction that produced good yields and very high crude purity (75%-85%). Seven compounds, identified within the library were shown to be more potent than V102862, our parent reference compound, in an electrophysiological assay measuring sodium channel antagonism. The most potent compound, 3-(2-piperidinylethyl)-2-(3-(3-trifluoromethylphenoxy)phenyl)thiazolidinone, has a Ki of 90 nM.
Keywords: parallel synthesis, biased library of thiazolidinones, novel sodium channel antagonists, anticonvulsant agent, sodium channel antagonism
Combinatorial Chemistry & High Throughput Screening
Title: Parallel Synthesis of a Biased Library of Thiazolidinones as Novel Sodium Channel Antagonists
Volume: 6 Issue: 5
Author(s): Qun Sun, Laykea Tafesse, James T. Limberis, Khondekar Islam and Donald J. Kyle
Affiliation:
Keywords: parallel synthesis, biased library of thiazolidinones, novel sodium channel antagonists, anticonvulsant agent, sodium channel antagonism
Abstract: A biased chemical library containing 91 differentially substituted thiazolidinones was prepared in an effort to improve the pharmacology of a known anticonvulsant agent V102862. The collection was prepared in a single step multi-component condensation reaction that produced good yields and very high crude purity (75%-85%). Seven compounds, identified within the library were shown to be more potent than V102862, our parent reference compound, in an electrophysiological assay measuring sodium channel antagonism. The most potent compound, 3-(2-piperidinylethyl)-2-(3-(3-trifluoromethylphenoxy)phenyl)thiazolidinone, has a Ki of 90 nM.
Export Options
About this article
Cite this article as:
Sun Qun, Tafesse Laykea, Limberis T. James, Islam Khondekar and Kyle J. Donald, Parallel Synthesis of a Biased Library of Thiazolidinones as Novel Sodium Channel Antagonists, Combinatorial Chemistry & High Throughput Screening 2003; 6 (5) . https://dx.doi.org/10.2174/138620703106298653
DOI https://dx.doi.org/10.2174/138620703106298653 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pathway to the Clinic: Inhibition of P38 MAP Kinase. A Review of Ten Chemotypes Selected for Development
Current Topics in Medicinal Chemistry The Medicinal Chemistry of Peptides
Current Medicinal Chemistry Role of Renin-Angiotensin System in Inflammation, Immunity and Aging
Current Pharmaceutical Design Sulodexide Down-Regulates the Release of Cytokines, Chemokines, and Leukocyte Colony Stimulating Factors from Human Macrophages: Role of Glycosaminoglycans in Inflammatory Pathways of Chronic Venous Disease
Current Vascular Pharmacology Non-IgE Mediated Food Allergy – Update of Recent Progress in Mucosal Immunity
Inflammation & Allergy - Drug Targets (Discontinued) Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies
Anti-Cancer Agents in Medicinal Chemistry Genetic Signatures in Ischemic Stroke: Focus on Aspirin Resistance
CNS & Neurological Disorders - Drug Targets Inhibition of NADPH: Quinone Oxidoreductase Activity of Camel Lens ζ-Crystallin by Colchicine
Current Enzyme Inhibition Topical Delivery of Drugs for the Effective Treatment of Fungal Infections of Skin
Current Pharmaceutical Design Bergamot (Citrus bergamia Risso) Flavonoids and Their Potential Benefits in Human Hyperlipidemia and Atherosclerosis: an Overview
Mini-Reviews in Medicinal Chemistry ADAM8 in Allergy
Inflammation & Allergy - Drug Targets (Discontinued) SARS: Understanding the Virus and Development of Rational Therapy
Current Molecular Medicine Consideration of Cytokines as Therapeutics Agents or Targets
Current Pharmaceutical Design New Therapeutic Strategies for Coeliac Disease: Tissue Transglutaminase as a Target
Current Medicinal Chemistry Differential Conservation of Nucleotides and Conservation/Mutation Correlations Between Nucleotides, with Special Reference to CXC 1 and 4 and FP Receptors Involved in Immune Regulation
Endocrine, Metabolic & Immune Disorders - Drug Targets Vitiligo: An Updated Narrative Review
Current Pediatric Reviews Optimizing Conventional Medical Therapies in Inflammatory Bowel Disease in 2014
Current Drug Targets Enantiomeric Resolution of (RS)-Naproxen and Application of (S)- Naproxen in the Direct and Indirect Enantioseparation of Racemic Compounds by Liquid Chromatography: A Review
Current Medicinal Chemistry Reduced Risk of Incident AD with Elective Statin Use in a Clinical Trial Cohort
Current Alzheimer Research SCF E3 Ubiquitin Ligases as Anticancer Targets
Current Cancer Drug Targets